Skip to site menu Skip to page content

Daily Newsletter

15 August 2023

Daily Newsletter

15 August 2023

Arunachal Pradesh in India to get tertiary care health services

The move will support research and training initiatives to boost the standard of care available to kidney patients in the state.

August 14 2023

The Government of Arunachal Pradesh (GoAP) has entered a memorandum of understanding (MoU) with Sir Ganga Ram Hospital and Religare Care Foundation (RCF) to enhance healthcare in the Indian state, reported NewsVoir.

The MoU was signed in Itanagar in the presence of Chief Minister Pema Khandu, Minister of Health Alo Libang, and other senior officials.

Facilitated by Religare's CSR arm, this collaboration aims to strengthen tertiary care health services in Arunachal Pradesh.

This initiative includes technical advisory support to the GoAP to address healthcare skill gaps and improve infrastructure.

The initial project under the MoU involves establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS).

The Center of Excellence is expected to deliver advanced healthcare services to individuals with kidney disorders.

Additionally, it will facilitate research and training initiatives aimed at enhancing the standard of care available to kidney patients within the state.

Arunachal Pradesh chief minister Pema Khandu said: “The memorandum of understanding is a step forward to fulfil the vision of providing affordable, accessible and equitable health care services to the people of Arunachal Pradesh.

“It is an endeavour of the government to bring the best of the tertiary health care services near to home thereby reducing the cost and also the psychological trauma the family has to go through for seeking such medical care.

“By joining hands with Sir Ganga Ram Hospital and Religare group, we look forward to bringing about changes that positively impact the lives of the people and also the entire Health care landscape of the State.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close